Arena Pharmaceuticals Inc
ARNA
ARNA was delisted on the 10th of March, 2022.
140 hedge funds and large institutions have $604M invested in Arena Pharmaceuticals Inc in 2013 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 55 increasing their positions, 37 reducing their positions, and 19 closing their positions.
49% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 37
37% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 19
4% more funds holding
Funds holding: 134 → 140 (+6)
23% less capital invested
Capital invested by funds: $787M → $604M (-$184M)
38% less call options, than puts
Call options by funds: $34.7M | Put options by funds: $56.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OppenheimerFunds
New York
|
+$40.3M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$17.9M |
| 3 |
State Street
Boston,
Massachusetts
|
+$11.8M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$7.6M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$7.44M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$20.3M |
| 2 |
DM
Deerfield Management
New York
|
-$9.08M |
| 3 |
Capital Fund Management (CFM)
Paris,
France
|
-$5.64M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$3.83M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$2.71M |
ARNA Hedge Fund Activity: Q3 2013 in Review
140 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q3 2013, worth a combined $604M — down 23% from $787M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new ARNA positions and 19 closed out — a net gain of 7 holders — while 55 added to existing stakes and 37 trimmed.
The largest buyer was OppenheimerFunds, adding an estimated $40.3M. The largest seller was Federated Hermes, exiting entirely with an estimated $20.3M sold.
- 140 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q3 2013, up from 134 in Q2 2013.
- Funds reported $604M of Arena Pharmaceuticals Inc stock for Q3 2013, down 23% quarter-over-quarter.
- 26 funds opened new Arena Pharmaceuticals Inc positions in Q3 2013 and 19 closed out, a net change of +7 holders.
- The largest Arena Pharmaceuticals Inc buyer in Q3 2013 was OppenheimerFunds, an estimated $40.3M added.
- The largest Arena Pharmaceuticals Inc seller in Q3 2013 was Federated Hermes, an estimated $20.3M sold.
Based on aggregated 13F filings for Q3 2013.